Loss of Cdkn1a protects against MASLD alone or with alcohol intake by preserving lipid homeostasis
Background & Aims: Expression of P21, encoded by the CDKN1A gene, has been associated with fibrosis progression in steatotic liver disease (SLD); however, the underlying mechanisms remain unknown. In the present study, we investigated the function of CDKN1A in SLD. Methods: CDKN1A expression...
Saved in:
Similar Items
-
Dynamic change of metabolic dysfunction-associated steatotic liver disease in chronic hepatitis C patients after viral eradication: A nationwide registry study in Taiwan
by: Chung-Feng Huang, et al.
Published: (2024-10-01) -
Optimization of the Proportion of Surfactant, Co-Surfactant, and Candlenut Oil for Self-Nanoemulsifying Drug Delivery System (SNEDDS) of Secang Heartwood (Caesalpinia sappan L.) Methanolic Extract
by: Anif Nur Artanti, et al.
Published: (2021-03-01) -
Comprehensive analysis of peripheral blood free amino acids in MASLD: the impact of glycine-serine-threonine metabolism
by: Masaaki Mino, et al.
Published: (2024-12-01) -
Current virtual reality-based rehabilitation interventions in neuro-developmental disorders at developmental ages
by: Micaela Capobianco, et al.
Published: (2025-01-01) -
BMI gain and dietary characteristics are risk factors of MASLD in non-obese individuals
by: Hirokazu Taniguchi, et al.
Published: (2025-01-01)